http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-24886-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
filingDate 1998-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0168057060abc6c0bd56c34ba8ccedb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84b711c2888e834d520f8d7aa81edc2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70990cab3ad4fe6e3b0856a21fc4cd87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd7c92f59b1d384c05784f21b8077876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55f680f4a031fad8412c0d4a9e1106ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f42280fe8c76b90d43bdecd9eee955
publicationDate 2001-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-24886-A1
titleOfInvention TIAZOLIDINDIONA
abstract Procedure for preparing derivatives of 1,3 thiazoles or 1,3 oxazoles comprising reducing a precursor thereof with complex hydride. The invention relates to an intermediate compound of formula (III) or one of its tautomeric forms, or of its salts, or of its solvates, where J is O or S; T represents a substituted or unsubstituted aryl group, for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof, where J is O or S; T is substituted aryl and T1 is O or S. Example: 5- (4- (2- (N-methyl-N- (2-pyridyl) amino) ethoxy) benzyl) -2,4-thiazolidinedione (IA) by reduction 5- (4- (2- (N-methyl-N- (2-pyridyl) amino) ethoxy) benzylidine) 2,4-thiazolidinedione (IIB)
priorityDate 1997-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534288

Total number of triples: 42.